Pfizer Avoids Japan R&D Layoffs With Creation Of New Business
This article was originally published in PharmAsia News
Executive Summary
Pfizer is spinning off some of its Nagoya, Japan, research site into a venture-backed start-up called RaQualia Pharma Inc., the company reported July 3
You may also be interested in...
Korea's CJ CheilJedang and Japan's RaQualia Pharma Partner For Gastrointestinal Therapies
SEOUL - South Korea's CJ CheilJedang signed a memorandum of understanding and subsequently a licensing agreement with Japan's RaQualia Pharma to establish a strategic alliance for the latter's innovative gastrointestinal therapies
Korea's CJ CheilJedang and Japan's RaQualia Pharma Partner For Gastrointestinal Therapies
SEOUL - South Korea's CJ CheilJedang signed a memorandum of understanding and subsequently a licensing agreement with Japan's RaQualia Pharma to establish a strategic alliance for the latter's innovative gastrointestinal therapies
Discovery Research In Japan By Global Pharmas: Evolving More Toward Partnerships? (Part 1 of 3)
While some globe-spanning pharmaceutical companies are maintaining or increasing their investment in discovery research in Japan, many more are moving in the opposite direction.